The risk of PFAS in medical devices continues to burden MedTech compliance teams as global regulations continue to accelerate. As scrutiny intensifies, manufacturers face growing pressure to understand where these substances exist and how to manage them effectively across complex supply chains. Most teams still cannot confidently identify PFAS in their products because supplier data remains incomplete, inconsistent, or difficult to access. Without material-level visibility, compliance efforts become reactive, slow, and difficult to defend under regulatory scrutiny.
This is where medical device software plays a critical role. As organizations look for scalable ways to improve visibility and control, many are turning to compliance solutions to streamline data collection, standardize reporting, and strengthen risk management. demonstrating how compliance software helps identify and manage risk in an increasingly complex regulatory environment.
MedTech manufacturers are expected to identify, track, and report PFAS in medical devices across complex global supply chains.
This creates two immediate risks:
The root issue is visibility. PFAS is rarely captured in a single system or dataset. Instead, it is buried across supplier declarations, material disclosures, and fragmented documentation.
To respond with confidence, teams need defensible, audit-ready data at the material level. Data based on supplier responses will no longer be enough to support compliance.
Read our blog for a deeper dive on per- and polyfluoroalkyl substances (PFAS) and how they impact regulations.
PFAS presents unique challenges compared to other regulated substances. First, it is widely used in medical devices. PFAS can be found in:
Second, substituting PFAS with safer alternatives is not simple. It often requires:
Third, supply chains are deep and dynamic. A single device may involve multiple tiers of suppliers, each with varying levels of data maturity and reliability.
This means compliance requires granular, material-level insight, not just supplier-level declarations. Without that depth, PFAS identification becomes unreliable.
Relying on suppliers opens up data gaps and process limitations that drive compliance risk. To mitigate risk, companies must consider compliance solutions that help them handle compliance challenges effectively.
Common medical device supply chain compliance challenges include:
The result is a compliance process that is:
Without structured data, PFAS identification becomes a best guess rather than a defensible position. Without the appropriate documentation for compliance reporting, companies risk penalties like fines and loss of market access.
To move forward, manufacturers need to replace fragmented workflows with a centralized, data-driven approach. PFAS compliance cannot be managed through manual processes. It requires scalable systems and end-to-end visibility across the supply chain.
Medical product compliance software enables this by:
This shift transforms the means of compliance for companies into something repeatable, saving time and effort as regulations continue to evolve.
For more information on key risks and requirements, read our blog on Medical Device Compliance Standards.
Beyond visibility, software enables faster and more informed decision-making. Manufacturers can quickly identify where PFAS exists, assess exposure risk, and respond to regulatory or customer requests with defensible data. `
The best medical device compliance software includes these key capabilities:
The outcome is measurable: faster response times, improved audit readiness, and reduced compliance risk. Instead of chasing data, teams can focus on proactive risk management and long-term material strategy.
Explore our software automation guide to see how leading teams streamline supplier data collection, improve response times, and stay ahead of evolving regulatory demands with centralized, automated compliance insights.
Source Intelligence’s PFAS solution simplifies medical device compliance by eliminating supplier data chaos. Instead of relying on supplier requests as the starting point, we aggregate and validate existing data across internal systems, commercial sources, and regulatory databases first. Supplier engagement is then used only to close true data gaps.
This data-first approach replaces fragmented, manual processes with a centralized and scalable foundation. As a purpose-built medical device compliance software, it enables teams to move faster, reduce supplier burden, and improve confidence in their compliance data as requirements evolve.
This data-first approach delivers:
With the right data foundation, PFAS compliance becomes more predictable, scalable, and aligned to business goals. See how Source Intelligence’s medical device software helps reduce PFAS risk and improve compliance outcomes.
Many medical devices contain PFAS, including implants, orthopedic components, surgical devices, catheters, tubing, contact lenses, surgical gloves, and blood bags. A commonly used PFAS is polytetrafluoroethylene (PTFE), which is applied as a coating on devices like stents and catheters to improve durability, flexibility, and biocompatibility while reducing wear, corrosion, and contamination.
Because PFAS are often embedded at the material or component level, they can be difficult to detect and disclose, creating challenges for accurate reporting and compliance.
PFAS compliance is challenging for medical device manufacturers because these substances are often embedded in critical materials that support product performance and safety, making them difficult to identify or replace. At the same time, complex, multi-tiered supply chains limit visibility into where PFAS are used, while supplier data is frequently incomplete, inconsistent, or based on differing regulatory definitions. This creates significant gaps in the information needed to assess and manage compliance effectively.
The best product compliance software for medical devices is built to solve a core challenge: managing complex, evolving regulatory requirements with incomplete and fragmented supplier data. To do this effectively, leading solutions must automate supplier engagement, centralize and validate product and material data, and streamline data collection workflows, ensuring teams can generate accurate, audit-ready reports at scale. Without these capabilities, organizations are forced into manual, reactive processes that increase risk and slow response times.
Source Intelligence’s medical device compliance software is designed for this reality, helping teams centralize supplier data, automate engagement, and close data gaps so they can prove compliance faster and with greater confidence.